immunity · Mechanism Report
Are rs2187668 and rs7454108 linked to celiac gluten susceptibility?
The rs2187668 and rs7454108 variants are strongly associated with HLA-DQ2/DQ8 celiac-risk haplotypes that increase gluten immune susceptibility.
This is what AI claimed
HLA-related rs2187668 and rs7454108 variants are linked to gluten immune susceptibility through HLA-DQ2/DQ8 celiac-risk haplotypes
Executive summary
These variants act as genetic proxies for the HLA-DQ2.5 and HLA-DQ8 haplotypes tied to celiac risk. The mechanism described is gluten peptide presentation by HLA class II molecules, which can activate CD4+ T cells and drive an inflammatory immune response. This association reflects susceptibility rather than a stand-alone diagnosis.
Verified conclusion
Celiac disease is a complex autoimmune enteropathy strongly governed by the human leukocyte antigen (HLA) class II locus. Genetic testing often utilizes specific single nucleotide polymorphisms (SNPs) as efficient proxies to identify individuals carrying high-risk HLA haplotypes.
Genetic association and proxy markers
- HLA-DQ2.5 Tagging: The SNP rs2187668, located in the first intron of HLA-DQA1, serves as an exceptionally strong tag variant for the high-risk HLA-DQ2.5 haplotype (DQA1*05:01-DQB1*02:01) with a linkage disequilibrium of $r^2 = 0.97$.
- HLA-DQ8 Tagging: The SNP rs7454108, located near HLA-DQB1, is a highly linked tag proxy used to infer the HLA-DQ8 haplotype (DQA1*03-DQB1*0302).
- Clinical Prevalence: Together, the HLA-DQ2 and HLA-DQ8 haplotypes are present in approximately 95% of all individuals diagnosed with celiac disease, making these two tag SNPs highly sensitive genetic screening markers.
Mechanistic pathway of gluten susceptibility
- Deamidation: In the small intestine, the enzyme tissue transglutaminase deamidates gluten-derived gliadin peptides, introducing negative charges.
- Antigen Presentation: The HLA-DQ2.5 and HLA-DQ8 molecules encode MHC class II heterodimers with positively charged peptide-binding grooves that exhibit a high affinity for these deamidated gluten peptides.
- T-Cell Activation: Once bound, these complexes present the gluten peptides to gluten-specific CD4+ T cells in the lamina propria, triggering an inflammatory cascade, autoantibody production, and mucosal tissue damage.
Bottom line
- The rs2187668 and rs7454108 variants are highly validated, sensitive genetic proxies for the HLA-DQ2.5 and HLA-DQ8 celiac-risk haplotypes, which directly drive gluten immune susceptibility through MHC class II presentation of deamidated gluten to CD4+ T cells. However, because many healthy carriers of these alleles never develop the condition, these markers are necessary but not sufficient for clinical diagnosis.
References
- TagSNP approach for HLA risk allele genotyping of Saudi ... — pmc.ncbi.nlm.nih.gov
- New 23andMe Report on Celiac Disease - 23andMe for Healthcare Professionals — medical.23andme.com
- A genome-wide association study for celiac disease identifies ... — pmc.ncbi.nlm.nih.gov
- rs2187668 - SNPedia — snpedia.com
- The Immunobiology and Pathogenesis of Celiac Disease. — annualreviews.org
- Genetic susceptibilty and celiac disease: what role do HLA ... - PMC — pmc.ncbi.nlm.nih.gov
- HLA genotyping in pediatric celiac disease patients - PMC — pmc.ncbi.nlm.nih.gov
- rs2187668 (HLA-DQA1) — genewizard.net — genewizard.net
- Celiac disease - SNPedia — snpedia.com
- HLA-DQ2 - Wikipedia — en.wikipedia.org
See a full patient report verified like this
Book a walkthrough